FIGS, Inc. (NYSE:FIGS - Free Report) - Equities researchers at Telsey Advisory Group issued their Q1 2025 EPS estimates for shares of FIGS in a research note issued on Friday, February 28th. Telsey Advisory Group analyst D. Telsey forecasts that the company will post earnings per share of $0.01 for the quarter. Telsey Advisory Group has a "Market Perform" rating and a $7.00 price target on the stock. The consensus estimate for FIGS's current full-year earnings is $0.01 per share. Telsey Advisory Group also issued estimates for FIGS's Q2 2025 earnings at $0.01 EPS, Q3 2025 earnings at ($0.01) EPS, Q4 2025 earnings at $0.01 EPS, FY2025 earnings at $0.02 EPS, Q1 2026 earnings at $0.00 EPS, Q2 2026 earnings at $0.01 EPS, FY2026 earnings at $0.06 EPS and FY2027 earnings at $0.10 EPS.
FIGS has been the subject of several other research reports. Barclays cut their price objective on FIGS from $5.00 to $4.00 and set an "equal weight" rating for the company in a research report on Tuesday, November 12th. The Goldman Sachs Group cut their price target on FIGS from $5.00 to $4.50 and set a "sell" rating for the company in a report on Tuesday, December 10th. Two investment analysts have rated the stock with a sell rating, three have issued a hold rating and one has issued a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of "Hold" and an average target price of $5.35.
Get Our Latest Stock Report on FIGS
FIGS Stock Up 0.7 %
FIGS stock traded up $0.04 during mid-day trading on Monday, reaching $4.88. 2,290,732 shares of the stock traded hands, compared to its average volume of 3,009,567. The firm has a market capitalization of $827.82 million, a PE ratio of 81.25, a P/E/G ratio of 31.62 and a beta of 1.26. The business has a 50-day moving average of $5.64 and a two-hundred day moving average of $5.76. FIGS has a 52 week low of $4.30 and a 52 week high of $7.06.
Insider Transactions at FIGS
In related news, insider Heather L. Hasson sold 26,855 shares of FIGS stock in a transaction dated Monday, January 6th. The stock was sold at an average price of $5.96, for a total value of $160,055.80. Following the completion of the transaction, the insider now directly owns 354,221 shares of the company's stock, valued at $2,111,157.16. The trade was a 7.05 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. 22.30% of the stock is owned by company insiders.
Hedge Funds Weigh In On FIGS
Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Pullen Investment Management LLC raised its stake in FIGS by 46.1% during the 4th quarter. Pullen Investment Management LLC now owns 112,236 shares of the company's stock worth $695,000 after buying an additional 35,434 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in shares of FIGS by 18.2% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 256,344 shares of the company's stock valued at $1,587,000 after buying an additional 39,462 shares during the period. Two Sigma Advisers LP bought a new stake in shares of FIGS during the fourth quarter worth $888,000. Two Sigma Investments LP raised its holdings in shares of FIGS by 151.9% during the fourth quarter. Two Sigma Investments LP now owns 433,432 shares of the company's stock worth $2,683,000 after acquiring an additional 261,367 shares during the period. Finally, ProShare Advisors LLC lifted its position in FIGS by 17.7% in the 4th quarter. ProShare Advisors LLC now owns 748,960 shares of the company's stock valued at $4,636,000 after acquiring an additional 112,722 shares in the last quarter. Institutional investors own 92.21% of the company's stock.
About FIGS
(
Get Free Report)
FIGS, Inc operates as a direct-to-consumer healthcare apparel and lifestyle company in the United States and internationally. It designs and sells healthcare apparel and scrubwear and non-scrubwear offerings, such as outerwear, underscrubs, footwear, compression socks, lab coats, loungewear, and other apparel.
Further Reading
Before you consider FIGS, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and FIGS wasn't on the list.
While FIGS currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
